在印度有抱负的地区获得必需药物的机会; 一个多站点的横截面研究
Bikash Ranjan Meher1, Biswa Mohan Padhy1, Rashmi Ranjan Mohanty2
1Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
基本药物在奥迪沙州普遍可用且价格合理.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 制药政策 制药政策
背景情况:
- 对必需药物 (EM) 的不公平获取阻碍了印度的医疗保健服务.
- 基线数据对于制定有效的公共卫生政策至关重要,以确保平等地获得EMS.
研究的目的:
- 调查奥迪沙州有抱负的地区的EM的价格,可用性和负担能力.
- 使用WHO/HAI方法进行全面评估.
主要方法:
- 在25家公共卫生机构和25家私人药房进行了这项研究.
- 收集了关于EMS可用性和定价的数据,将价格与使用中位价比 (MPR) 的国际参考价格 (IRP) 进行比较.
- 评估了接受调查的EMS的治疗负担能力.
主要成果:
- 最低价格仿制药 (LPG) 的总体可用性在公共设施中为62%,在私人药房中为58%.
- 公共设施的采购价格是IRP的0.28倍;零售价格是IRP的1.34倍.
- 大多数急性病的EM是负担得起的,除了阿莫西西林/克拉夫兰酸625毫克.
结论:
- 在公共和私营部门接受调查的EMS的可用性是最佳的.
- 与IRP相比,EM的采购和患者价格是合理的.
- 提高EMS的可用性和负担能力表明,对改善偏远地区的访问有积极的政策影响.
更多相关视频
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
相关概念视频
Bioequivalence of Drugs: Drugs with Multiple Indications
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Study Design: Single Versus Multiple Dose Studies
